Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 5/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.35 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.35 |
| ▸ | CCNT1 | O60563 | 6/20 | 0.35 |
| ▸ | CDK9 | P50750 | 6/20 | 0.35 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4665742 | 0.88 | PRKCB (0.40) | TNNI3KEGFRGSK3BMKNK2ERBB3 | |
| SCHEMBL4667477 | 0.88 | EGFR (0.35) | EGFRCCNT1CDK9PRKCALCK | |
| SCHEMBL4666179 | 0.87 | PRKCA (0.35) | EGFRCCNT1CDK9PRKCALCK | |
| SCHEMBL4665992 | 0.86 | CYP1A2 (0.35) | KMT2AEGFRCCNT1CDK9MEN1 | |
| Formic Acid SCHEMBL4667436 | 0.86 | KMT2A (0.40) | KMT2ATNNI3KEGFRMKNK1MKNK2 | |
| SCHEMBL4665626 | 0.83 | BPTF (0.39) | EGFRCCNT1CDK9 | |
| SCHEMBL4667523 | 0.82 | HTR6 (0.38) | TNNI3KEGFRCCNT1CDK9 | |
| SCHEMBL4664313 | 0.79 | HTR6 (0.42) | TNNI3KEGFRCCNT1CDK9 | |
| SCHEMBL4666211 | 0.77 | BPTF (0.40) | KMT2AEGFRMEN1 | |
| SCHEMBL4665682 | 0.77 | ABL1 (0.38) | KMT2ATNNI3KCCNT1CDK9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080242681-A1 | N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors | ALTANA PHARMA AG (DE) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242681-A1 | N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors | MAP3K19, MAP3K6, MAP3K20 | KMT2A 997/4885TNNI3K 25/4885EGFR 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.